ArticlePharmaceuticals (Basel, Switzerland)2023

Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies.

Nathupakorn Dechsupa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.